Results 76 - 89 from 89 for "antibiotice"
-
Antibiotice Vetoes Capital Hike, Pays Dividend Instead
04.27.2012
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) Friday rejected a proposal to increase its share capital by 17.2 million lei (EUR3.93 million), authorizing instead a dividend payout from the more
-
Antibiotice Proposes RON17.2M Share Capital Hike
03.23.2012
The managing board of Romanian state-owned medicine maker Antibiotice Iasi (ATB.RO) increased to 17.2 million lei (EUR3.9 million) the sum proposed to stockholders as share capital hike, according to more
-
Antibiotice Sees Pretax Profit Up 13%, To RON29.9M In 2012
03.14.2012
Romanian state-owned medicine maker Antibiotice Iasi (ATB.RO) expects pretax profit to reach 29.9 million lei (EUR6.86 million) this year, up 13% from RON26.4 million in the previous year, according more
-
Biofarm Emerges As Most Profitable Pharma Company On Bucharest Bourse
02.20.2012
Biofarm (BIO.RO) was the most profitable pharmaceuticals company on the Bucharest stock exchange last year. Despite a two-percentage point drop in net profit margin to 15.5%, the drugmaker surpassed more
-
Antibiotice Net Profit Rises 60% To RON20M In 2011
02.13.2012
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) Monday said its net profit rose 60% to 20 million lei (EUR4.7 million) in 2011, fueled by a 15% increase in sales. more
-
Antibiotice Posts 17.7% Rise In 9-Mo Net Profit, To RON24.85M
11.14.2011
Romanian state-owned medicine maker Antibiotice Iasi (ATB.RO) on Monday reported a 17.7% year-on-year increase in its nine-month net profit, to 24.85 million lei (EUR5.9 million), form RON21.11 more
-
Antibiotice Sees 36% Higher Exports To US In 2012
10.24.2011
State-owned drugmaker Antibiotice Iasi SA (ATB.RO) estimates its sales on the US market will grow 36% on the year to $4.5 million in 2012, after it has received official authorization to trade a new more
-
Antibiotice To Sell Medicine Worth RON68M Through Pharma Iasi
09.06.2011
Romanian medicine maker Antibiotice Iasi (ATB.RO) on Tuesday corrected to 68 million lei (EUR16 million), from RON50 million, the value of the medicine sale contract inked with wholesaler Phama Iasi. more
-
Antibiotice To Sell Medicine Worth RON50M Through Pharma Iasi
08.19.2011
Pharmaceutical wholesaler Pharma Iasi recently signed a deal to buy medicine worth an estimated 50 million lei (EUR11.75 million) this year from Antibiotice (ATB.RO), according to an Antibiotice news more
-
Antibiotice Iasi's 1H Pretax Profit Up 35% On Year
08.11.2011
Romanian state-owned drugmaker Antibiotice Iasi (ATB.RO) reported a pretax profit of 28.2 million lei (EUR6.6 million) in the first half, up 35% on the year, the company said in a statement Thursday. more
-
Antibiotice Invests EUR12M In New Production Facility
08.04.2011
Romanian pharmaceutical producer Antibiotice Iasi (ATB.RO) invests EUR12 million in expanding production capacity, which will allow production of latest generation of anti-infective drugs to be more
-
Antibiotice 1Q Net Profit Rises 22% On Higher Sales
05.13.2011
Romanian state-owned drugmaker Antibiotice Iasi SA (ATB.RO) Friday said its first-quarter net profit rose 22% on the year to 13.2 million lei (EUR3.1 million), on higher sales. more
-
Drugmaker Antibiotice To Borrow EUR6.5M From RBS Bank
04.28.2011
Shareholders of Romanian medicine maker Antibiotice (ATB.RO) on Thursday approved the contracting of a EUR6.5 million loan from RBS Bank and the capitalization of 9 million lei (EUR2.21 million) from more
-
Romanian Antibiotice Plans EUR6.5M Loan From RBS
03.28.2011
The managing board of Romanian medicine maker Antibiotice Iasi (ATB.RO) on Monday asked shareholders to approve a EUR6.5 million loan from lender RBS Romania. more
